Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21044839 | 1.00 | ALDH1A1 (0.30) | ALDH1A1TSHR | |
| SCHEMBL21044842 | 0.87 | TSHR (0.41) | ALDH1A1TSHR | |
| SCHEMBL21044843 | 0.87 | TSHR (0.41) | ALDH1A1TSHR | |
| SCHEMBL21044827 | 0.81 | TRPA1 (0.36) | — | |
| SCHEMBL21044828 | 0.81 | TRPA1 (0.36) | — | |
| SCHEMBL731193 | 0.74 | ALDH1A1 (0.43) | ALDH1A1TSHR | |
| SCHEMBL731194 | 0.74 | ALDH1A1 (0.43) | ALDH1A1TSHR | |
| SCHEMBL21044861 | 0.73 | TSHR (0.33) | ALDH1A1TSHR | |
| SCHEMBL21044862 | 0.73 | TSHR (0.33) | ALDH1A1TSHR | |
| SCHEMBL5439418 | 0.72 | TSHR (0.39) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10442821-B2 | Method for releasing unsaturated aldehyde or ketone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2019-10-15 | — | — | US | disclosed |
| US-20190185494-A1 | METHOD FOR RELEASING UNSATURATED ALDEHYDE OR KETONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2019-06-20 | — | — | US | disclosed |
| EP-3492570-A1 | METHOD FOR RELEASING UNSATURATED ALDEHYDE OR KETONE | Takasago International Corporation (JP) | 2019-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190185494-A1 | METHOD FOR RELEASING UNSATURATED ALDEHYDE OR KETONE | FAAH2, ALDH1A1, FASN | ALDH1A1 2/4885TSHR 2871/4885 |
| US-10442821-B2 | Method for releasing unsaturated aldehyde or ketone | FAAH2, ALDH1A1, FASN | ALDH1A1 2/4885TSHR 2871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.